Stock Rich List
#1139 on the rich list of 14,452 insiders

Helmut Wolfgang Jeggle

Director at Bambusa Therapeutics; Director at BioNTech SE. Based in Boston, Massachusetts.

$144M
in disclosed stock, −$3.2M (−2.20%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
1139th of 14,452
Companies held
1
Largest holding
BBTX, 100.0% of total
Latest SEC filing
Nov 2, 2026
Listed but not counted
$80.5M

What the $144M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Bambusa Therapeutics BBTX
Common Stock
Through Salvia Investment GmbH9,264,301$15.55$144M100.0%Form 4, Nov 2, 2026

Share counts are the amounts Helmut Wolfgang Jeggle reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Helmut Wolfgang Jeggle's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
BioNTech SE BNTX
Ordinary Shares
Indirectly (see filing footnote)
Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio
656,951$81.38$53.5M—Form 3, Mar 18, 2026
BioNTech SE BNTX
Ordinary Shares
Directly
Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio
332,316$81.38$27.0M—Form 3, Mar 18, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 2, 2026BoughtBBTX375,000$16.00$6.0MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
1136Scott J. Branch
Insider, StoneX Group. New York, NY
$145M−$52.7M (−26.71%)
1137Celia Wiley
10% owner, John Wiley & Sons. Sacramento, CA
$144M+$2.9M (+2.06%)
1138Jesse C. Wiley
Director, John Wiley & Sons. Sacramento, CA
$144M+$2.9M (+2.06%)
1139Helmut Wolfgang Jeggle
Director, Bambusa Therapeutics. Boston, MA
$144M−$3.2M (−2.20%)
1140Sandesh Kaveripatnam
Director, Navan. Palo Alto, CA
$144M−$3.8M (−2.60%)
1141Anthony F. Markel
Director, Markel Group. Glen Allen, VA
$144M+$846K (+0.59%)
1142Rene A. Lacerte
CEO, BILL Holdings. San Jose, CA
$143M−$4.3M (−2.92%)

Other Bambusa Therapeutics insiders

All BBTX insiders

Questions

How much stock does Helmut Wolfgang Jeggle own?

Helmut Wolfgang Jeggle holds $144,059,881 in listed stock based on SEC filings and current prices, mostly Bambusa Therapeutics (BBTX). That ranks 1139th on the Stock Rich List.

Is this Helmut Wolfgang Jeggle's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Helmut Wolfgang Jeggle last buy or sell stock?

The most recent open-market trade on file is a purchase of 375,000 BBTX shares on Nov 2, 2026 at $16.00.